SRC
SEM

Sage Rhino Capital’s Select Medical SEM Stock Holding History

Sage Rhino Capital’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,878
Closed -$204K – 293
2024
Q3 		$204K Buy
10,878
+100
+0.9% +$1.92K 0.05% 247
2024
Q2 		$204K Buy
+10,778
New +$184K 0.05% 220

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Sage Rhino Capital's SEM Position: Q4 2024 in Review

Sage Rhino Capital sold out of Select Medical (SEM) in Q4 2024, closing a stake of 10,878 shares — an estimated $204K sold.

Sage Rhino Capital first reported a position in SEM in Q2 2024 and held it in 2 quarters. The position peaked at $204K in Q3 2024. 271 funds tracked by Wall St. Rank hold SEM as of Q4 2024.

  • Sage Rhino Capital reported no remaining Select Medical position as of Q4 2024 after selling out during the quarter.
  • Sage Rhino Capital sold 10,878 Select Medical shares in Q4 2024, an estimated $204K.
  • Sage Rhino Capital first reported a position in Select Medical in Q2 2024 and held it in 2 quarters.
  • Sage Rhino Capital's Select Medical position peaked at $204K in Q3 2024.
  • 271 funds tracked by Wall St. Rank held Select Medical as of Q4 2024.

Based on Sage Rhino Capital's 13F filing for Q4 2024, filed 6 Feb 2025.